Summary: Reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection T Lion, on behalf of the participants of the current round of the Debate
The reports from a number of European diagnostic centers presented in this round of the Debate on Chimerism Testing reveal several technical aspects of great relevance to the clinical monitoring of post-transplant chimerism. The main advantages of automated fluorescence-based detection of microsatellite markers over the use of conventional polyacrylamide gel electrophoresis (PAGE) include greater precision and easier performance of quantitative analysis, reduced manual handling of PCR products, and higher sensitivity. Important features and potential problems of the technique discussed in the contributions to the debate are summarized below.
Informativeness
Only a limited number of highly polymorphic microsatellite loci needs to be tested to provide an informative marker in virtually all donor/recipient constellations. In matched sibling and haploidentical transplants more markers are generally required in order to differentiate between donor and recipient cells as compared to the unrelated setting. The screening panels used at the above centers include 6-15 microsatellite markers. In most instances, genotyping with 3-5 markers is sufficient to reveal allelic differences between recipient-and donor-derived cells suitable for the analysis of chimerism.
Eligibility of markers for chimerism testing
The criteria presented in the reports for the selection of informative markers are not quite uniform. (a) Some groups require the presence of at least one unique donor and recipient allele for a marker to be eligible. Others define the presence of a unique recipient allele distinguishable from the donor allele(s) as the minimum requirement for the monitoring of residual recipient hemopoiesis. (b) As a general rule, informative donor and recipient alleles must be separated by at least two repeat units to prevent interference with stutter peaks. (c) Due to preferential amplification of short fragments during PCR cycling, minor recipient cell populations may be detected with greater sensitivity if the informative recipient alleles are shorter in length than any donor allele. However, the importance of this criterion for marker selection when using fluorescence-based analysis is not entirely clear. Although microsatellite markers usually show relatively small differences in length between alleles, some authors stress that amplification efficiencies may nevertheless differ significantly and therefore have an impact on the sensitivity of the assays.
Sensitivity
The reported average sensitivity in detecting minor (in most instances recipient-derived) cell populations using different microsatellite markers ranges from 1 to 5%. The sensitivity may to a large extent depend on the size of the informative recipient allele(s), the allelic constellation and the number of alleles co-amplified. In practice, however, some markers from the panels used at individual centers tend to provide higher sensitivity than others and are therefore used preferentially.
The amount of template DNA in the PCR reactions can also play a role. Most investigators use 50-100 ng of template (corresponding to about 7.5 × 10 3 -15 × 10 3 diploid human cells), a quantity readily available when analyzing chimerism within the entire white blood cell population. In such instances it is feasible to reproducibly detect residual recipient cell populations in the range of 1% (ie about 100 cells). This level of sensitivity may not be readily achievable, however, when specific white blood cell fractions isolated by flowsorting or by magnetic bead separation are investigated. In these instances, only small cell numbers are available for DNA isolation yielding no more than 1-10 ng of DNA (corresponding to about 1.5 × 10 2 -1.5 × 10 3 cells). Although 1% sensitivity (equivalent to detecting about 10 cells or less) can be obtained even in this experimental setting, it is more common to achieve sensitivities around 3-5%. Despite the slightly decreased sensitivity of assays using low cell numbers as starting material, the overall sensitivity in detecting minor autologous cell fractions within specifically enriched leukocyte populations is generally one to two logs higher than chimerism analysis in whole white blood cell preparations.
Reproducibility
The reported inter-assay variation between repeated quantitative analyses of DNA samples is low. Multiple capillary electrophoreses of the same PCR specimens revealed a variation of peak areas below 5%, and re-amplification of DNA samples resulted in differences between quantitative measurements of less than 10%. The variation between repeated analyses may be higher between samples with low levels of chimerism.
Multiplex PCR analysis
Investigation of a post-transplant DNA sample with multiple microsatellite markers may improve the reproducibility and accuracy of quantitative chimerism analysis. Some investigators therefore perform clinical testing of chimerism with commercial multiplex kits facilitating co-amplification of several microsatellite markers in a single PCR reaction. However, the advantages indicated above are counterbalanced by significantly higher cost of consumables and lower sensitivity resulting from the high number of different fragments coamplified. Most diagnostic centers therefore rely on the use of singleplex PCR reactions for chimerism analysis. Multiplex PCR assays are sometimes used for initial recipient/donor genotyping to select one or more informative markers for the monitoring of chimerism. If post-transplant DNA samples are tested by more than one microsatellite marker, amplification is usually performed in separate PCR reactions.
Quantitative analysis
Quantification of the degree of mixed chimerism is carried out relative to a patient-specific standard curve established from serial dilutions of pre-transplant recipient in donor DNA. For each patient, standard curves are produced for one or more informative microsatellite markers.
For quantitative analysis of donor and recipient alleles, both peak height and peak area can in principle be used. Peak areas, however, were shown to provide better reproducibility and should therefore be preferred. The formula used for calculating the degree of (most commonly recipient) chimerism is based on the quotient between recipient and donor allele areas. However, the number and type of alleles used for the calculation may differ among centers. Most investigators include all unique recipient and donor alleles in the calculation, while shared alleles are excluded. Others select only one unique allele from each recipient and donor for the calculation.
The accuracy of quantitative chimerism analysis can be increased by testing each sample with more than one marker and calculating mean values. 
Time requirement, sample throughput and cost
The employment of capillary electrophoresis instruments requires less hands-on time than conventional gel electrophoresis due to the automated loading of samples, electrophoresis and measurement of fluorescence signals. However, the capacity of devices with a single capillary and an average electrophoresis time of 30 minutes per sample may be a limiting factor for sample throughput. The efficiency can be improved by loading PCR products of different chimerism assays onto the capillary and analyzing all fragments in the same run. This can be done when primers for amplification of various microsatellite loci are labeled with different dyes, thus permitting easy identification of the products after electrophoresis. These considerations are certainly of relevance at major diagnostic centers, where high sample throughput is required. Alternatively, instruments with multiple capillaries can be used.
Currently, the overall cost of capillary electrophoresis with Leukemia fluorescence-based detection of PCR products is considerably higher than conventional analysis using PAGE. This is attributable both to the required equipment and the consumables. The variation in the reported cost of chimerism assays at various European centers may result from differences in the price of reagents, cost of labor and sample throughput.
Potential problems
Capillary electrophoresis-based product analysis seems to be sensitive to variations in DNA template quality. It is necessary therefore to use isolation protocols yielding very high quality DNA in order to obtain reproducible results and satisfactory sensitivity. Most centers currently use DNA isolation kits from Qiagen Inc. (Hilden, Germany) which have proven to be adequate for this application.
The so-called stutter peaks resulting from polymerase slippage during the amplification of microsatellite loci typically migrate at a distance of one repeat unit in front of the parent allele and may interfere with specific allelic peaks. This problem must be accounted for by judicious marker selection, as indicated above.
The occurrence of dye-associated non-specific peaks is a problem peculiar to the technology discussed. Apparently, the fluorescent dyes FAM, HEX and NED may give rise to formation of multiple template-independent peaks at positions characteristic for each dye. The peaks are relatively high and migrate in a range similar to that of many microsatellite markers. The signals may therefore interfere with specific microsatellite peaks and thus compromise the analysis of chimerism. There is currently no reasonable explanation for this phenomenon. A feasible approach to eliminate this problem is having primers for each microsatellite locus labelled with different fluorescent dyes and selecting a primer/dye combination that does not show any interference between the specific alleles of the marker used and the dye-associated peak positions.
Future prospects
The need for standardization of chimerism assays to permit better comparison of results between laboratories has been stressed by several authors. The implementation of capillary electrophoresis instruments displaying a high degree of automation provides an excellent opportunity for the establishment of standardized approaches to chimerism analysis. A recently established European consortium including 14 leading diagnostic centers will collaborate in a Concerted Action supported by the European Commission (Eurochimerism Concerted Action, EC Grant QLRT 01485) to establish optimized and standardized protocols for chimerism testing based on capillary electrophoresis and fluorescence detection. The European harmonized diagnostic approaches to chimerism analysis which will emanate from the collaborative study will greatly facilitate multicenter clinical studies in patients undergoing allogeneic stem cell transplantation. The current Debate on Chimerism Testing pursued in Leukemia will serve as the platform for presenting the forthcoming results of the European Concerted Action to the scientific community.
